Since then, the dysregulation of the PI3K/PTEN/AKT/mTOR pathway has been observed in a variety of human cancers, including cancers of the endometrium, stomach, lung, and esophagus8, 9, 10, 11, 12, 13, 14, 15. This evidence concerns the gene PTEN and cancer.